Skip to main content

Table 3 Analyses of factors affecting top-quality Day 3 embryos (TQE) in POSEIDON Group 4 patients using logistic regression

From: Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles

 

1 TQE

TQE rate50

Adjusted OR

(95% CI)

P value

Adjusted OR (95% CI)

P value

AOA vs. non-AOA

3.24 (1.63–6.45)

0.001

2.14 (1.20–3.80)

0.010

Age (years)

1.05 (0.94–1.18)

0.386

1.02 (0.93–1.13)

0.658

BMI (kg/m2)

1.01 (0.92–1.10)

0.845

0.97 (0.90–1.05)

0.496

Previous IVF attempts

0.83 (0.55–1.25)

0.361

0.80 (0.56–1.12)

0.193

Types of infertility

0.70 (0.36–1.33)

0.269

0.85 (0.49–1.47)

0.552

Basal FSH (IU/l)

1.03 (0.97–1.09)

0.378

1.03 (0.97–1.08)

0.364

AFC (n)

1.00 (0.88–1.13)

0.943

0.99 (0.89–1.11)

0.891

AMH (ng/mL)

0.47 (0.16–1.41)

0.179

0.82 (0.32–2.07)

0.670

No. of MII oocytes (n)

2.19 (1.65–2.91)

< 0.001

1.20 (1.03–1.41)

0.024

  1. OR Odds ratio, CI Confidence interval, AOA Artificial oocyte activation, BMI Body mass index, IVF in vitro fertilization, FSH Follicle-stimulating hormone, AFC Antral follicle count, AMH Anti-Müllerian hormone, MII Metaphase II